UK markets open in 4 hours 20 minutes

Omega Therapeutics, Inc. (OMGA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.2800-0.3000 (-11.63%)
At close: 04:00PM EDT
2.2600 -0.02 (-0.88%)
After hours: 07:57PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 125.75M
Enterprise value 193.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)25.46
Price/book (mrq)3.04
Enterprise value/revenue 62.49
Enterprise value/EBITDA -2.07

Trading information

Stock price history

Beta (5Y monthly) 1.83
52-week change 3-69.36%
S&P500 52-week change 324.49%
52-week high 310.0900
52-week low 31.3000
50-day moving average 33.2284
200-day moving average 33.1027

Share statistics

Avg vol (3-month) 3394.85k
Avg vol (10-day) 3309.62k
Shares outstanding 555.16M
Implied shares outstanding 662.41M
Float 821.36M
% held by insiders 11.97%
% held by institutions 194.49%
Shares short (15 Apr 2024) 44.43M
Short ratio (15 Apr 2024) 414.22
Short % of float (15 Apr 2024) 423.13%
Short % of shares outstanding (15 Apr 2024) 48.04%
Shares short (prior month 15 Mar 2024) 43.88M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-2,092.92%

Management effectiveness

Return on assets (ttm)-35.77%
Return on equity (ttm)-118.82%

Income statement

Revenue (ttm)3.09M
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)34.60%
Gross profit (ttm)N/A
EBITDA -98.69M
Net income avi to common (ttm)-97.43M
Diluted EPS (ttm)-1.8000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)73.43M
Total cash per share (mrq)1.33
Total debt (mrq)128.43M
Total debt/equity (mrq)221.37%
Current ratio (mrq)3.35
Book value per share (mrq)1.05

Cash flow statement

Operating cash flow (ttm)-91.51M
Levered free cash flow (ttm)-60.18M